D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 129 SEK -1.9% Market Closed
Market Cap: 2.1B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Devyser Diagnostics AB
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Gross Profit
kr144.8m
CAGR 3-Years
45%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Gross Profit
kr950.2m
CAGR 3-Years
20%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Gross Profit
kr752.8m
CAGR 3-Years
60%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Gross Profit
kr2.1B
CAGR 3-Years
27%
CAGR 5-Years
18%
CAGR 10-Years
20%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Gross Profit
kr20B
CAGR 3-Years
19%
CAGR 5-Years
17%
CAGR 10-Years
30%
BioArctic AB
STO:BIOA B
Gross Profit
kr565.1m
CAGR 3-Years
144%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Devyser Diagnostics AB
Glance View

Market Cap
2.1B SEK
Industry
Biotechnology

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

DVYSR Intrinsic Value
124.21 SEK
Overvaluation 4%
Intrinsic Value
Price
D

See Also

What is Devyser Diagnostics AB's Gross Profit?
Gross Profit
144.8m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Gross Profit amounts to 144.8m SEK.

What is Devyser Diagnostics AB's Gross Profit growth rate?
Gross Profit CAGR 5Y
35%

Over the last year, the Gross Profit growth was 40%. The average annual Gross Profit growth rates for Devyser Diagnostics AB have been 45% over the past three years , 35% over the past five years .

Back to Top